CROI 2015 Program and Abstracts

Poster Listings

853 Intimate Partner Violence and Antiretroviral Adherence in HIV-Positive Women in Kenya Kate S. Wilson 1 ; KristaYuhas 1 ; Ruth Deya 1 ; Barbra Richardson 1 ; Linnet Masese 1 ; Jane Simoni 1 ;Walter Jaoko 2 ; R Scott McClelland 1 1 University of Washington, Seattle, WA, US; 2 University of Nairobi, Nairobi, Kenya 854 Re-engagement in Care Leads to Sustained Engagement and Viral Suppression Brittani D. Saafir-Callaway 1 ; Amanda D. Castel 2 ; Lena Lago 1 ; Christie Olejemeh 1 ; Garret Lum 1 ; Lawrence Frison 1 ; Michael Kharfen 1 1 District of Columbia Department of Health, Washington, DC, US; 2 The Milken Institute School of Public Health at George Washington University, Washington, DC, US 2:30 pm– 4:00 pm Cervical Sampling, Shedding, and Outcomes 855 Symptoms and Genital HSV-2 and HIV-1 in CoinfectedWomen, Chiang Rai, Thailand Eileen F. Dunne 1 ; Brooke E. Hoots 1 ; Janet McNicholl 1 ; SaraWhitehead 2 ;Thomas A. Peterman 2 ; Lauri E. Markowitz 2 ;Wanna Leelawiwat 3 ;Tammy Evans-Strickfaden 1 ; Cheng Chen 1 1 US Centers for Disease Control and Prevention, Bangkok, Thailand; 2 US Centers for Disease Control and Prevention, Atlanta, GA, US; 3 Thailand Ministry of Public Health–US CDC Collaboration, Nonthaburi, Thailand 856 High-Risk HPV Clustering and Cervical Outcomes in HIV-InfectedWomen in Rio de Janeiro, Brazil Jessica L. Castilho 1 ; José Eduardo Levi 2 ; Paula M. Luz 2 ; Mary Catherine Cambou 3 ;Tazio Vanni 4 ; Angela de Andrade 2 ; Monica Derrico 2 ;ValdileaVeloso 2 ; Beatriz Grinsztejn 2 ; Ruth Friedman 2 1 Vanderbilt University School of Medicine, Nashville, TN, US; 2 Fundação Oswaldo Cruz, Rio de Janeiro, Brazil; 3 University of California Los Angeles, Los Angeles, CA, US; 4 United Nations, Lyons, France 857 Comparison of Three Female Genital Tract Sampling Techniques for HIV RNA Recovery Catherine S. Todd 1 ; Shameem Jaumdally 2 ; Heidi E. Jones 3 ; Hoyam Gamieldien 2 ; Nontokozo Langwenya 4 ; Landon Myer 4 ; Donald R. Hoover 5 ; Jo-Ann Passmore 1 1 FHI360, Bangkok, Thailand; 2 University of Cape Town, Cape Town, South Africa; 3 Hunter College, CUNY School of Public Health, New York, NY, US; 4 University of Cape Town, Cape Town, South Africa; 5 Rutgers New Jersey Medical School, Piscataway, NJ, US 2:30 pm– 4:00 pm Hormonal Contraception 858 CCR5 Expression in HIV-UninfectedWomen Receiving Hormonal Contraception Athe Tsibris 1 ; Gaia Sciaranghella 2 ; CuiweiWang 3 ; Kerry Murphy 4 ; Zaher Mehri 5 ; Ruth M. Greenblatt 6 ; Mardge Cohen 7 ; Elizabeth Golub 8 ; HeatherWatts 9 ; Mary A.Young 3 1 Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, US; 2 Ragon Institute of MIT, MGH and Harvard, Boston, MA, US; 3 Georgetown University Medical Center, Washington, DC, US; 4 Albert Einstein College of Medicine, Bronx, NY, US; 5 University of Vermont College of Medicine, Burlington, VT, US; 6 University of California San Francisco, San Francisco, CA, US; 7 Stroger Hospital and Rush University and CORE Center, Chicago, IL, US; 8 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US; 9 The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, US TUESDAY, FEBRUARY 24, 2015 Session P-S2 Poster Session Poster Hall THURSDAY, FEBRUARY 26, 2015 Session P-S3 Poster Session Poster Hall

859 Estrogen Replacement in Healthy Postmenopausal Women Reduces %CCR5+ CD4+ T Cells Amie Meditz 1 ; Samantha MaWhinney 2 ; Kerrie Moreau 2 ; Kelsey Melander 2 ; Joy Folkvord 2 ; Wendy Kohrt 2 ; MargaretWierman 2 ; Elizabeth Connick 2 1 Boulder Community Health, Boulder, CO, US; 2 University of Colorado Anschutz Medical Campus, Aurora, CO, US 860 Progesterone Increases Are AssociatedWith HIV Susceptibility Factors in Women AlisonY. Swaims 1 ;Tammy Evans-Strickfaden 1 ; L Davis Lupo 1 ; Alfredo Aguirre 2 ; Anandi Sheth 2 ; Igho Ofotokun 2 ; Clyde E. Hart 1 ; Richard E. Haaland 1 1 US Centers for Disease Control and Prevention (CDC), Atlanta, GA, US; 2 Emory University School of Medicine, Atlanta, GA, US 861 Changes in Vaginal Microbiota and Cytokines in HIV-1-Seronegative Women Initiating DMPA Alison C. Roxby 1 ; David N. Fredricks 2 ; Katherine Odem-Davis 1 ; Kristjana H. Ásbjörnsdóttir 1 ; Linnet Masese 1 ;Tina L. Fiedler 2 ;Walter Jaoko 3 ; James N. Kiarie 3 ; Julie M. Overbaugh 2 ; R Scott McClelland 1 1 University of Washington, Seattle, WA, US; 2 Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, US; 3 University of Nairobi, Nairobi, Kenya 862 A Thinned Vaginal Stratum Corneum Is a Susceptibility Factor for SHIV Acquisition Ellen Kersh ; Jana Ritter; Katherine Butler; Sharon Dietz Ostergaard; Debra Hanson; Sherif Zaki; Janet McNicholl US Centers for Disease Control and Prevention, Atlanta, GA, US 2:30 pm– 4:00 pm How Fast? How Often? Achieving Viral Suppression in Pregnant and PostpartumWomen 863 Specific Effects of ZDV, 3TC and LPV/r on HIV-1 RNA Viral Load During Pregnancy Patumrat Sripan 1 ; Sophie Le Coeur 5 ; Lily Ingsrisawang 2 ;Tim R. Cressey 3 ; Jean-Marc Tréluyer 6 ; Naïm Bouazza 4 ; Frantz Foissac 4 ; Gonzague Jourdain 3 ; Marc G. Lallemant 3 ; Saïk Urien 7 1 ED420, University of Paris Sud 11, Paris Descartes, Paris, France/PHPT-IRD UMI 174, Chiang Mai, Thailand/Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand; 2 Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand; 3 PHPT-IRD UMI 174, Faculty of Associated Medical Sciences, Chiang Mai University/ Harvard School of Public Health, Chiang Mai, Thailand; 4 EA 08 Université Paris Descartes, Sorbonne Paris Cité, Unité de Recherche Clinique, AP-HP, Hôpital Tarnier, Paris, France; 5 Institut d’Etudes Démographiques, Institut de Recherche Pour le Développement (UMR 196 CEPED), Paris, France/Harvard School of Public Health, Boston, MA, USA/Faculty of Associated Medical Science, Chiang Mai University, Chiang Mai, Thailand; 6 EA 08 Université Paris Descartes, Sorbonne Paris Cité, Unité de Recherche Clinique, AP-HP, Hôpital Tarnier, Service de Pharmacologie Clinique, AP-HP, Groupe Hospitalier Paris Centre, CIC-0901 Inserm, Cochin- Necker, Paris, France; 7 EA 08 Université Paris Descartes, Sorbonne Paris Cité, Unité de Recherche Clinique, AP-HP, Hôpital Tarnier, CIC-0901 Inserm, Cochin-Necker, Paris, France 864 Viral Suppression After Antiretroviral Therapy Initiation in Pregnancy in South Africa Landon Myer 1 ;Tamsin Phillips 1 ; Nei-Yuan Hsiao 2 ; Allison Zerbe 3 ; Jo Ramjith 1 ; Linda-Gail Bekker 1 ; James A. McIntyre 4 ; Elaine J. Abrams 3 1 University of Cape Town, Cape Town, South Africa; 2 National Health Laboratory Services/ University of Cape Town, Cape Town, South Africa; 3 ICAP at Columbia University, New York, NY, US; 4 Anova Health Institute, Johannesburg, South Africa TUESDAY, FEBRUARY 24, 2015 Session P-T1 Poster Session Poster Hall

Poster Listings

66

CROI 2015